TNFSF11 and osteosarcoma: Receptor activator of nuclear factor kappa-B ligand (RANKL), a tumor necrosis factor, is associated with the formation, activation, and function of osteoclasts as well as increased rates of metastasis and cell mobility in osteosarcoma.